FBIOP:NASDAQ
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
$16.75
arrow_upward
+0.48%(+0.080) 1D
Oct 19, 10:55:21 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FBIOP...
Open
$16.75
High
$16.75
Low
$16.65
Mkt. cap
61.70M
Avg. vol.
13.05K
Volume
561.00
52-wk high
$21.43
52-wk low
$6.27
Beta
0.92
Shares outstanding
3.43M
No. of employees
78
Open
$16.75
High
$16.75
Low
$16.65
Mkt. cap
61.70M
Avg. vol.
13.05K
Volume
561.00
52-wk high
$21.43
52-wk low
$6.27
Beta
0.92
Shares outstanding
3.43M
No. of employees
78
News stories
From web sources and news partners
finance.biggo.com
·
39 minutes ago
He makes 3 decisions a year (and beat the S&P 500 for 11 years)｜My First Million
Devdiscourse
·
29 minutes ago
US STOCKS-S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
RealMoney Pro
·
31 minutes ago
Charting the Markets: The S&P Is Still Bullish. But for How Long?
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.08% Lower
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
CEOLindsay Rosenwald
Employees78
Founded2006
HeadquartersBay Harbor Islands, Florida, United States
SectorBiotechnology
Websitefortressbiotech.com